Global Statistics

All countries
97,306,536
Confirmed
Updated on January 21, 2021 3:25 am
All countries
69,629,101
Recovered
Updated on January 21, 2021 3:25 am
All countries
2,083,257
Deaths
Updated on January 21, 2021 3:25 am

COVID-19 Global Statistics

All countries
97,306,536
Confirmed
Updated on January 21, 2021 3:25 am
All countries
69,629,101
Recovered
Updated on January 21, 2021 3:25 am
All countries
2,083,257
Deaths
Updated on January 21, 2021 3:25 am

Support Corruption-Free

Supporting Corruption-Free isn’t a transaction for an online service. Our Community is for people like you who care about a common good: ensuring that balanced, independent coverage of Nigeria and the world continues to be available to millions across the world, for free.

Russia says it developed COVID-19 treatment based on anti-malaria drug

Report: Former US President Plans to Flee the White House early

In the wake of yesterday's shocking riots and after finally admitting defeat in November's presidential election, Donald Trump - along with wife...

Larry King, hospitalized with COVID, moved out of ICU

LOS ANGELES — Veteran talk show host Larry King, suffering from COVID-19, has been moved out of the intensive care unit at...

America’s Fate To Be Decided in Two Days

Civil war or the will of the people? The events on two days in the next two weeks will...

‘Amen and Awoman’: Democrat Lawmaker Delivers Very Unusual Opening Prayer for 117th Congress

Rep. Emanuel Cleaver (D-Mo.) — an ordained Methodist minister — opened the first session of the 117th U.S. Congress on Sunday by...

New Year Party! New Zealand farewells 2020, welcomes 2021

Kiwis around the country are partying to farewell 2020 and welcome in the new year. Thousands of people are...

Russia’s Federal Biomedical Agency on Saturday said it has developed a drug for the treatment of COVID-19.

The agency said its drug was based on mefloquine, which is used to prevent or treat malaria.

The drug will allegedly provide effective treatment for COVID-19 patients with varying severity.

According to the agency’s statement, the drug prevents virus replication in cells and as a result, stops the inflammatory process caused by the virus.

Veronika Skvortsova, the agency’s head, said Mefloquine has to be combined with antibiotics for the maximum effect, allowing an increase in the concentration of antiviral agents in blood plasma and lungs.

“This will ensure effective treatment of patients with various degrees of coronavirus infection,” Skvortsova said.

The agency said it was developing an effective and safe scheme for the prevention of coronavirus on the basis of mefloquine.

The treatment was developed taking Chinese and French experience into account, it added.

COVID-19 treatment, for now, focuses on relieving symptoms such as breathing assistance.

Companies around the world are racing to develop vaccines. A few have launched early safety testing in humans, but experts say it could take a year or more to develop and test a vaccine.

Hot Topics

Report: Former US President Plans to Flee the White House early

In the wake of yesterday's shocking riots and after finally admitting defeat in November's presidential election, Donald Trump - along with wife...

Larry King, hospitalized with COVID, moved out of ICU

LOS ANGELES — Veteran talk show host Larry King, suffering from COVID-19, has been moved out of the intensive care unit at...

America’s Fate To Be Decided in Two Days

Civil war or the will of the people? The events on two days in the next two weeks will...

Related Articles

Report: Former US President Plans to Flee the White House early

In the wake of yesterday's shocking riots and after finally admitting defeat in November's presidential election, Donald Trump - along with wife...

Larry King, hospitalized with COVID, moved out of ICU

LOS ANGELES — Veteran talk show host Larry King, suffering from COVID-19, has been moved out of the intensive care unit at...

America’s Fate To Be Decided in Two Days

Civil war or the will of the people? The events on two days in the next two weeks will...